Product Images Dextrose 5%

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Dextrose 5% NDC 85268-803 by Huaren Pharmaceutical Co., Ltd., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Dextrose 5% 1000 mL Bag Label - Dextrose 5 1000 ml

Dextrose 5% 1000 mL Bag Label - Dextrose 5  1000 ml

This text provides details about a glucose injection in a 1000ml/5% solution, housed in a non-PVC co-extruded film. It features a double hard tube and double valve and plug for ease of use. The product is intended to supplement energy and body fluids and serves as a drug diluent. The instructions outline dosage, usage, precautions, contraindications, adverse reactions, and storage recommendations. The product is marketed by Huaren Pharmaceutical Co., Ltd., with details such as batch number, manufacturing date, and expiration date included for reference.*

Dextrose 5% 100 mL Bag Label - Dextrose 5 100ml

Dextrose 5% 100 mL Bag Label - Dextrose 5  100ml

This is a description of a 100ml Glucose Injection solution with a concentration of 5%. It is packaged in a non-PVC co-extruded film with a double hard tube, double valve, and double plug for easy use. The medication is used to supplement energy and body fluids, and can also serve as a drug diluent. Users are advised to follow the instructions provided in the manual for proper dosage and administration through intravenous infusion. Precautions, contraindications, and adverse reactions information are also available in the instructions. The product should be stored in a sealed container and checked for any signs of damage before use. The pharmaceutical marketing authorization holder and the manufacturer are listed as Huaren Pharmaceutical Co., Ltd. Additional details such as batch number, manufacturing date, and expiration date are also provided.*

Dextrose 5% 250 mL Bag Label - Dextrose 5 250 ml

Dextrose 5% 250 mL Bag Label - Dextrose 5  250 ml

This is a description of a 250ml Glucose Injection solution contained in a Non-PVC co-extruded film with additional features like a double hard tube, easy break-apart system, double valve, and double plug. The purpose of this product is to supplement energy and body fluids, serve as a drug diluent, and should be administered through Intravenous Infusion as per the doctor's advice. The product should be stored sealed and checked for leakage, unclear liquid, or visible particles before use. The pharmaceutical marketing authorization holder and manufacturer of this product is Huaren Pharmaceutical Co., Ltd.*

Dextrose 5% 50 mL Bag Label - Dextrose 5 50 ml

Dextrose 5% 50 mL Bag Label - Dextrose 5  50 ml

This description provides details about a 50ml/5% Glucose Injection, packaged in a non-PVC co-extruded film with double hard tube, double valve, and double plug for easy use. It is indicated for supplementing energy and body fluids as well as a drug diluent. The prescribed dosage is for intravenous infusion as per the doctor's instructions. Precautions, contraindications, and adverse reactions are detailed in the instructions. The product should be stored sealed and checked for any issues before use. The manufacturer is Huaren Pharmaceutical Co., Ltd.*

Dextrose 5% 500 mL Bag Label - Dextrose 5 500 ml

Dextrose 5% 500 mL Bag Label - Dextrose 5 500 ml

This is a description of a 500ml glucose injection contained in a non-PVC co-extruded film with a 5% concentration. It features a double hard tube, easy-to-break design, double valve, and double plug. The product is indicated for supplementing energy and body fluids, serving as a drug diluent. Dosage instructions include intravenous infusion under a doctor's guidance. Precautions, contraindications, and adverse reactions are detailed in the instructions. The product should be sealed and stored properly, and users are advised to check for leaks, clarity of the liquid, and visible particles before use. The product is from Huaren Pharmaceutical Co., Ltd. with specified batch, manufacturing, and expiration dates.*

HEALTH CARE PROVIDER LETTER pg.1 - HC Letter pg1 Glucose injection 5

HEALTH CARE PROVIDER LETTER pg.1 - HC Letter pg1  Glucose injection 5

The text provides information about the temporary importation of 5% Glucose Injection (Dextrose) products from Qingdao City to address drug shortages in the United States. Smith Associates is working with the U.S. Food and Drug Administration (FDA) to import these products from HUAREN PHARMACEUTICAL CO., LTD. The FDA has authorized only Smith Associates to distribute these products. Various package sizes of the 5% Glucose Injection (Dextrose) are listed along with their corresponding NDC codes. Healthcare providers receiving these imported products are advised to read each letter carefully as they may contain different product-specific information.*

HEALTH CARE PROVIDER LETTER pg.2 - HC Letter pg2 Glucose injection 5

HEALTH CARE PROVIDER LETTER pg.2 - HC Letter pg2  Glucose injection 5

This text provides important information related to a 5% Glucose Injection (Dextrose) product, including cautions, usage instructions, and contact details for reporting adverse events. It also highlights key differences between FDA-approved and imported products. Healthcare providers should refer to the FDA-approved prescribing information and report any adverse reactions or quality issues to the appropriate channels provided in the text.*

HEALTH CARE PROVIDER LETTER pg.3 - HC Letter pg3 Glucose injection 5

HEALTH CARE PROVIDER LETTER pg.3 - HC Letter pg3 Glucose injection 5

This is a letter that provides information about administering Huaren's 5% Glucose Injection (Dextrose) and contains contact details for Smith Associates. The letter includes instructions for placing an order and information on who to contact for inquiries. It also lists the names, titles, phone numbers, and email addresses of representatives from Huaren Pharmaceutical and Smith Associates. The letter mentions that the manufacturer's and distributor's signatures, email, and phone numbers are required.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.